AstraZeneca is a global, science-led, patient-focused biopharmaceutical company committed to discovering, developing, and commercializing prescription medicines for serious diseases. Within Hematology R&D, the team focuses on advancing science to deliver life-changing medicines for patients with hematological cancers. The Hematology Research and Early Development (R&D) team is responsible for all drug development activities in hematology research, from first-in-man studies to late-stage trials leading to regulatory approval (Phase 1, 2, and 3). The team aims to deliver compelling data packages to support investment in late-stage clinical development. This role is for a highly qualified Global Clinical Program Lead (GCPL) to lead the clinical development and execution of product strategy for multiple projects. The individual will be accountable for the strategic clinical development plan and clinical execution of compounds, reporting to the Global Clinical Head (GCH) of the disease indication. The role involves articulating project goals, strategy, science, and clinical need to internal and external audiences, and collaborating with project leaders, scientific and clinical leaders, and external experts to coordinate integrated project plans across functional boundaries. The candidate will foster an empowered and motivated team and demonstrate leadership within the oncology community. A strong background in hematology/oncology clinical drug development, demonstrated leadership, and the ability to critically navigate the underlying science are essential. Effective communication across diverse audiences and the ability to articulate project-specific and overall oncology strategies are key.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree